Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
about
Argininosuccinate synthase: at the center of arginine metabolismOcular Blood Flow and Normal Tension GlaucomaCurrent trends in the monitoring and treatment of diabetic retinopathy in young adultsGlaucomatous neurodegeneration: an eye on tumor necrosis factor-alphaCurrent concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatmentInterrelationships between the Retinal Neuroglia and Vasculature in DiabetesVitreous mediators in retinal hypoxic diseaseseNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetesPresence and Risk Factors for Glaucoma in Patients with Diabetes.Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts.Association between eNOS 4b/a polymorphism and the risk of diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis.Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up studyRetinal metabolic events in preconditioning light stress as revealed by wide-spectrum targeted metabolomics.Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arteriolesThe α₁B -adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium.Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis.Association of known common genetic variants with primary open angle, primary angle closure, and pseudoexfoliation glaucoma in Pakistani cohorts.Association of genetic polymorphisms of eNOS with glaucoma.Molecular Implications of the PPARs in the Diabetic Eye.Optic nerve head blood flow autoregulation during changes in arterial blood pressure in healthy young subjects.Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study.Comparison of Risk Factor Profiles for Primary Open-Angle Glaucoma Subtypes Defined by Pattern of Visual Field Loss: A Prospective Study.Common variants near CAV1 and CAV2 are associated with primary open-angle glaucomaLight modulation, not choroidal vasomotor action, is a regulator of refractive compensation to signed optical blurLack of association of SNP rs4236601 near CAV1 and CAV2 with POAG in a Saudi cohortNeuropathy optic glaucomatosa induced by systemic hypertension through activation endothelin-1 signaling pathway in central retinal artery in rats.The Association Between Primary Open Angle Glaucoma and Clustered Components of Metabolic Syndrome.Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.Targets of tyrosine nitration in diabetic rat retina.Association of Common Variants in eNOS Gene with Primary Open Angle Glaucoma: A Meta-AnalysisEarly iNOS impairment and late eNOS enhancement during reperfusion following 2.49 MHz continuous ultrasound exposure after ischemia.Targeting the retinal microcirculation to treat diabetic sight problems.High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs.Maturation of the fetal human choriocapillaris.Hypoxia-ischemia and retinal ganglion cell damage.Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma?The Extract of Aster Koraiensis Prevents Retinal Pericyte Apoptosis in Diabetic Rats and Its Active Compound, Chlorogenic Acid Inhibits AGE Formation and AGE/RAGE Interaction.
P2860
Q24620561-4FFD2D7B-3C02-4B0E-9944-2B050EAA94CFQ26777589-A671901D-C1BC-4E3E-858B-402EBE625BDDQ26863388-A877E53E-CDF1-4BF3-BDDF-5289FCC78650Q27011820-086375CA-FC7F-44B4-8D62-811ED9C3380CQ27015027-32708018-3CE1-4F80-AB23-1CDBA3DC562FQ27028003-6762D773-BDBC-4390-8BFB-501598117022Q27028225-316CB700-01E9-4A67-BD0A-A3B0C2BACA5BQ28256901-1FFEC9F5-956C-4C69-83EF-AB810F4503EBQ30244246-C3088353-20FF-4EA3-B7F5-04A9FC1FFBC5Q33538038-9F5989D2-07D4-47BC-ACE2-5C2E841CF18EQ33586390-9158D0EF-ED6D-4D0F-B3B2-F8507AEDDB54Q33661735-CA083346-058B-420B-9AE9-8A4E6C495ADAQ33811789-7CDC763D-E77E-4099-B5DE-4EE20181CAA7Q33841046-7DF58A84-6BEB-413C-92CF-3DBC8A5ACBDBQ33845154-CF5ADC64-6D75-4162-863D-DFDE88697029Q34025089-13407D24-18E5-4966-B487-ACEC46B9ACE4Q34066154-28106964-A240-4E8C-A716-53F00937A225Q34476050-91778A3E-CA26-4455-B495-39EB26FB2384Q34493805-29EA11FB-B52E-412C-A66E-6A89CACB07A9Q34594935-E7AC1551-1994-4630-9B91-704BDD22DA60Q35064155-D69BD784-0CA7-493A-AFF3-B50D964267F8Q35157723-7CFBA0AD-DFDA-4CF8-9483-F0F5693952CFQ35187253-48BB91AB-C2F9-434B-8A44-4952353C8A26Q35535213-1C1826C4-B5ED-4D32-A199-D0A3B9EBAAE2Q35569618-02A9C235-7946-42BE-B9FF-B36E52C511A7Q35593055-6F281DA2-22BB-47A4-AEAD-13A95516AD55Q36145925-56F22D3C-40A1-4779-9E71-B2EA082D22B2Q36227651-F11FB88A-E109-4626-AAAD-ADC47F023CD8Q36232318-ACB31507-CB83-473D-822A-28CD69881CEFQ36249969-75CF60D9-C412-4980-9CF0-CFBF52FC71DAQ36250613-F718FEEA-F5A3-4255-BC80-DF6E3A6B94D2Q36685034-E2E0347C-E2BB-41C8-A09D-B60897CD7BD4Q36924168-55BAAB17-2A6C-4BDE-A84E-B785B0D6BFCEQ36965252-455B8D06-398E-48F1-A94E-35ABE600EC76Q37008851-9A779358-DFB7-4F68-84DE-F9D0FD05A7A3Q37016720-6245F99D-E02A-45CD-8B01-64F6CD748D04Q37085761-BA854BFA-D3B4-4ECE-B49E-E0488B5FD3F9Q37236104-CC800ED4-AEBB-4DC0-A2C0-BF19F38AEDA6Q37236114-9980247A-771D-4B64-8B3F-495A60B3F030Q37285945-175A4AF3-573D-42E5-B927-0AFD85C50138
P2860
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
@en
type
label
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
@en
prefLabel
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
@en
P1476
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
@en
P2093
Megumi Nakanishi-Toda
Noboru Toda
P304
P356
10.1016/J.PRETEYERES.2007.01.004
P577
2007-01-20T00:00:00Z